Exocrine Pancreatic Insufficiency
📧 Sign up to get email alerts when something new happens for Exocrine Pancreatic Insufficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-11-08Clinical Trial Update: Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer [Phase 4]
Phase 4 trial of oral CREON capsules in adults with Exocrine Pancreatic Insufficiency has been withdrawn.
-
EMA withdrawal · 2021-02-17EMA Withdrawn: Enzepi (pancreas powder) — Allergan Pharmaceuticals International Limited
The EMA has withdrawn Enzepi (pancreas powder) for exocrine pancreatic insufficiency.
-
CLINICAL_TRIALS withdrawal · 2014-06-20Clinical Trial Update: A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2 [Phase 4]
A Phase 4 clinical trial evaluating Creon (pancrelipase) for pancreatic exocrine insufficiency in subjects with type 2 diabetes mellitus has…